The Chemours Company (CC)
| Previous close | 27.08 |
| Open | 27.01 |
| Bid | 26.78 x 800 |
| Ask | 26.80 x 1100 |
| Day's range | 26.39 - 27.04 |
| 52-week range | 15.10 - 39.05 |
| Volume | |
| Avg. volume | 2,068,011 |
| Market cap | 3.981B |
| Beta (5Y monthly) | 2.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.00 (3.69%) |
| Ex-dividend date | 23 Feb 2024 |
| 1y target est | N/A |
- Zacks
Stepan Co. (SCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Stepan Co. (SCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Analysts Estimate Chemours (CC) to Report a Decline in Earnings: What to Look Out for
Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Bloomberg
EPA Sets US’s First Drinking Water Standards to Limit Toxic PFAS
(Bloomberg Law) -- About 100 million people will be exposed to fewer cancer-causing “forever chemicals” under the country’s first-ever drinking water standards for PFAS finalized Wednesday by the EPA, White House officials said. Most Read from BloombergUS Slams Strikes on Russia Oil Refineries as Risk to Oil MarketsUS Inflation Refuses to Bend, Fanning Fears It Will Get StuckChinese Cement Maker Halted After 99% Crash in 15 MinutesBond Trader Places Record Futures Bet on Eve of Inflation DataApp
